AlbionVC

About The Fund

AlbionVC, a division of Albion Capital Group LLP and based in the United Kingdom, operates as a venture capital firm specializing in seed investments. As an investor with a focus on building the future of digital health, medtech, SaaS, fintech, artificial intelligence, digital risk, life science, and computer and physical science sectors, AlbionVC stands out for its commitment to supporting visionary founders by providing long-term capital and scale-up expertise. Since its foundation in 1996, the firm has become known for its deep sector knowledge and ability to identify and nurture high-growth companies. Their investment thesis revolves around early-stage B2B software, healthcare, and deep tech companies, aiming to partner with businesses that can deliver transformative solutions and drive significant advancements within their respective fields. AlbionVC takes pride in its strong track record of scaling businesses from lab to market, evident in their success stories and portfolio growth. In 2024, AlbionVC demonstrated its impact by raising £84 million, making 11 new investments, and achieving a milestone with one portfolio company, Quantexa, reaching $100 million in ARR. The firm's contribution extends beyond financial metrics, having created over 5,170 jobs and improving patient outcomes by supporting innovations in HealthTech. Furthermore, AlbionVC places emphasis on diversity within its investment strategy, supporting 14 women founders and promoting internal progress with four partner promotions. They engage in thought leadership within the investment community, exploring key trends in deep tech, particularly in AI and hardware, offering insights that are valuable for both founders and investors through their content series. The investor profiles and founder stories shared on their website highlight the substantial and enduring relationships AlbionVC fosters with their portfolio companies, an element central to their philosophy of building successful, sustainable businesses.